Monday, 21 October 2019

WuXi to establish presence in Boston, SF by 2015

16 December 2014 | News | By BioSpectrum Bureau

WuXi to establish presence in Boston, SF by 2015

WuXi PharmaTech plans to expand its operations in US

WuXi PharmaTech plans to expand its operations in US

Singapore: China-based research and development service provider, WuXi PharmaTech, plans to expand its operations in US by opening offices in Boston and San Francisco by early 2015.

The company has established facilities in St Paul, Philadelphia, Atlanta, Plainsboro (NJ), and San Diego. In October 2014, WuXi opened an office in Israel to tap into biotech opportunities there.

"Our vision is to enable anyone and any company to discover and develop healthcare products to benefit the world's patients," said Dr Ge Li, chairman and CEO, WuXi PharmaTech. "These new offices bring our comprehensive platform of integrated R&D services closer to where entrepreneurs are and where cutting-edge science is being done."

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Is Asia-Pacific dominating the global digital transformation in healthcare market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls